Evommune Inc.
EVMN | NYSE
$6.22
-$0.51 (-7.58%)
Nov 2, 2026, 11:42 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
Cash & Equivalents | 44.06M | 16.25M | 29.02M |
Short-Term Investments | 105.14M | 55.79M | 50.06M |
Long-Term Investments | 68.9M | 208K | 208K |
Other Long-Term Assets | 101K | 61K | 44K |
Receivables | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a |
Other Current Assets | 4.28M | 1.95M | 948K |
Total Current Assets | 153.48M | 73.99M | 80.03M |
Property-Plant & Equipment | 2.46M | 1.8M | 1.97M |
Goodwill & Intangibles | n/a | n/a | n/a |
Total Long-Term Assets | 71.47M | 2.07M | 2.22M |
Total Assets | 224.95M | 76.06M | 82.25M |
Account Payables | 7.76M | 8.26M | 1.76M |
Deferred Revenue | n/a | 3M | n/a |
Short-Term Debt | 589K | 1.02M | 769K |
Other Current Liabilities | 4.63M | 12.07M | 1.89M |
Total Current Liabilities | 17.91M | 27.98M | 6.86M |
Long-Term Debt | n/a | 191.78M | 149.37M |
Other Long-Term Liabilities | n/a | 16K | 245K |
Total Long-Term Liabilities | 1.47M | 192.31M | 153.11M |
Total Liabilities | 19.38M | 220.29M | 159.96M |
Total Debt | 2.06M | 193.31M | 150.63M |
Book Value | 205.57M | -144.24M | -77.71M |
Book Value Per Share | 6.52 | -4.80 | -2.58 |
Common Stock | 3K | 1K | 1K |
Retained Earnings | -221.09M | -152.22M | -83.91M |
Comprehensive Income | n/a | n/a | n/a |
Shareholders Equity | 205.57M | -144.24M | -77.71M |
Total Investments | 174.04M | 55.99M | 50.27M |
Add to Watchlist
Select watchlists to add or remove EVMN